The Generation of the Human mAb RabD4 Specific to the Rabies Virus Glycoprotein and Characterization Thereof


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

We generated a novel human neutralizing human mAb RabD4 against rabies virus glycoprotein using in vitro stimulation of human peripheral B cells produced by immunized donor. The human mAb RabD4 showed a high antigen-binding activity and virus-neutralizing activity in the FAVN test with the CVS-11 rabies virus.

Sobre autores

E. Ilina

Moscow State University

Autor responsável pela correspondência
Email: Ekaterina.iljina.7@yandex.ru
Rússia, Moscow, 119991

E. Solopova

All-Russia Research Center of Molecular Diagnostics
and Therapy

Email: Ekaterina.iljina.7@yandex.ru
Rússia, Moscow, 117149

T. Aliev

Moscow State University

Email: Ekaterina.iljina.7@yandex.ru
Rússia, Moscow, 119991

M. Larina

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: Ekaterina.iljina.7@yandex.ru
Rússia, Moscow, 117997

D. Balabashin

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: Ekaterina.iljina.7@yandex.ru
Rússia, Moscow, 117997

N. Varlamov

All-Russia Research Center of Molecular Diagnostics
and Therapy

Email: Ekaterina.iljina.7@yandex.ru
Rússia, Moscow, 117149

D. Dolgikh

Moscow State University; Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: Ekaterina.iljina.7@yandex.ru
Rússia, Moscow, 119991; Moscow, 117997

P. Sveshnikov

All-Russia Research Center of Molecular Diagnostics
and Therapy

Email: Ekaterina.iljina.7@yandex.ru
Rússia, Moscow, 117149

M. Kirpichnikov

Moscow State University; Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: Ekaterina.iljina.7@yandex.ru
Rússia, Moscow, 119991; Moscow, 117997

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Inc., 2019